Skip to content

Towards an Early Integration of Palliative Care in Oncology

Towards an Early Integration of Palliative Care in Oncology: Descriptive Study of Needs for Patients With Metastatic Cancer and the Adequacy of These Needs With Healthcare Facilities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05339945
Acronym
BESACE
Enrollment
361
Registered
2022-04-21
Start date
2022-06-02
Completion date
2024-10-21
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Cancer, Palliatives Treatments

Keywords

metastatic cancer, palliative care, oncology, health needs, early integration

Brief summary

The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagnosis to death. As secondary objectives, the study aims: * to determinate the proportion of patients with an indication for palliative care according to Hui et al., and to describe the adequation of health needs and the services for them; * to study the association between clinical pathway and the indication of targeted palliative care; * to study the association between the integration of palliative care service and the adequation of health needs service of patients; * to study the factors such as the disease, the practice and the care, contribute to the patient's survivor of 1 year.

Detailed description

This is a descriptive, transversal, multicenter study, which will be performed in healthcare facilities in Ile de France area. Each investigator center will be composed by oncologist / palliative care and support team. 10 centers will participate to the study, enrollement will be perfomed during 6 months targetting 400 patients with advanced cancer.

Interventions

None listed

Sponsors

Fondation de France
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years; * Diagnosed metastatic cancer; * Outpatient or inpatient care at a participating site to the study; * Affiliation to the social security scheme; * Patient informed and non-opposed to participate to the study.

Exclusion criteria

* Testicular or choriocarcinoma ovarian cancer; * Hematology cancer; * No understanding french language; * Unable to express if needed his non-opposition opinion, according to physician investigator; * Visually impaired, hearing impaired or aphasic.

Design outcomes

Primary

MeasureTime frameDescription
Auto-evaluationat baselineEvaluation by patient and principal caregiver the health needs. Questionnaires: EORTC-QLQ C30

Secondary

MeasureTime frameDescription
Description of diseaseat baseline
Clinical trajectory descriptionat baseline
Proportion (%) of patients needing palliative treatmentat the end of study
Survivor (%)at 1 yearVital statute of patients at 1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026